JPY 809.0
(-0.12%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.06 Billion JPY | -0.03% |
2022 | 1.06 Billion JPY | -20.82% |
2021 | 1.34 Billion JPY | 33.92% |
2020 | 1 Billion JPY | -10.91% |
2019 | 1.12 Billion JPY | -14.68% |
2018 | 1.32 Billion JPY | 9.01% |
2017 | 1.21 Billion JPY | -2.49% |
2016 | 1.24 Billion JPY | 17.31% |
2015 | 1.05 Billion JPY | -8.17% |
2014 | 1.15 Billion JPY | 11.77% |
2013 | 1.03 Billion JPY | -41.31% |
2012 | 1.75 Billion JPY | -11.35% |
2011 | 1.98 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.06 Billion JPY | -5.43% |
2024 Q1 | 1.12 Billion JPY | 5.84% |
2023 Q3 | 1.09 Billion JPY | 1.08% |
2023 Q4 | 1.06 Billion JPY | -2.47% |
2023 Q1 | 1.08 Billion JPY | 1.6% |
2023 Q2 | 1.07 Billion JPY | -0.19% |
2023 FY | 1.06 Billion JPY | -0.03% |
2022 Q4 | 1.06 Billion JPY | -1.8% |
2022 Q2 | 1.07 Billion JPY | -7.52% |
2022 Q1 | 1.16 Billion JPY | -13.24% |
2022 FY | 1.06 Billion JPY | -20.82% |
2022 Q3 | 1.08 Billion JPY | 0.49% |
2021 FY | 1.34 Billion JPY | 33.92% |
2021 Q1 | 1.18 Billion JPY | 18.24% |
2021 Q3 | 1.38 Billion JPY | 23.43% |
2021 Q2 | 1.12 Billion JPY | -5.24% |
2021 Q4 | 1.34 Billion JPY | -3.17% |
2020 Q4 | 1 Billion JPY | -20.94% |
2020 FY | 1 Billion JPY | -10.91% |
2020 Q1 | 1.2 Billion JPY | 6.99% |
2020 Q2 | 1.22 Billion JPY | 1.57% |
2020 Q3 | 1.26 Billion JPY | 3.69% |
2019 Q2 | 1.22 Billion JPY | -0.41% |
2019 FY | 1.12 Billion JPY | -14.68% |
2019 Q3 | 1.19 Billion JPY | -2.28% |
2019 Q1 | 1.22 Billion JPY | -6.93% |
2019 Q4 | 1.12 Billion JPY | -5.81% |
2018 Q2 | 1.3 Billion JPY | -2.4% |
2018 FY | 1.32 Billion JPY | 9.01% |
2018 Q4 | 1.32 Billion JPY | 3.3% |
2018 Q1 | 1.33 Billion JPY | 10.1% |
2018 Q3 | 1.27 Billion JPY | -1.8% |
2017 Q4 | 1.21 Billion JPY | -11.35% |
2017 Q3 | 1.36 Billion JPY | 16.83% |
2017 Q2 | 1.16 Billion JPY | -9.21% |
2017 Q1 | 1.28 Billion JPY | 3.69% |
2017 FY | 1.21 Billion JPY | -2.49% |
2016 Q4 | 1.24 Billion JPY | -3.18% |
2016 Q2 | 1.21 Billion JPY | -17.65% |
2016 Q1 | 1.47 Billion JPY | 39.59% |
2016 FY | 1.24 Billion JPY | 17.31% |
2016 Q3 | 1.28 Billion JPY | 5.4% |
2015 Q1 | 1.13 Billion JPY | -1.31% |
2015 FY | 1.05 Billion JPY | -8.17% |
2015 Q3 | 1.07 Billion JPY | 0.24% |
2015 Q4 | 1.05 Billion JPY | -1.13% |
2015 Q2 | 1.06 Billion JPY | -6.11% |
2014 Q3 | 1.1 Billion JPY | 1.24% |
2014 Q1 | 1.1 Billion JPY | 6.7% |
2014 FY | 1.15 Billion JPY | 11.77% |
2014 Q4 | 1.15 Billion JPY | 4.02% |
2014 Q2 | 1.09 Billion JPY | -0.54% |
2013 Q1 | 1 Billion JPY | -43.02% |
2013 Q2 | 983.65 Million JPY | -1.82% |
2013 Q3 | 1.13 Billion JPY | 15.73% |
2013 Q4 | 1.03 Billion JPY | -9.35% |
2013 FY | 1.03 Billion JPY | -41.31% |
2012 Q4 | 1.75 Billion JPY | -9.5% |
2012 Q3 | 1.94 Billion JPY | 0.0% |
2012 FY | 1.75 Billion JPY | -11.35% |
2011 FY | 1.98 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | 35.615% |
Euglena Co., Ltd. | 37.92 Billion JPY | 97.194% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | 83.61% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 92.702% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 95.02% |
Kao Corporation | 757.7 Billion JPY | 99.86% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 88.627% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 98.927% |
Shiseido Company, Limited | 615.1 Billion JPY | 99.827% |
Lion Corporation | 188.22 Billion JPY | 99.435% |
Mandom Corporation | 20.05 Billion JPY | 94.694% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | 19.8% |
Milbon Co., Ltd. | 7.45 Billion JPY | 85.735% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 92.153% |
Fancl Corporation | 30.56 Billion JPY | 96.519% |
KOSÉ Corporation | 88.61 Billion JPY | 98.799% |
Cota Co., Ltd. | 3.85 Billion JPY | 72.38% |
HABA Laboratories,Inc. | 3.92 Billion JPY | 72.883% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | 66.207% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 96.801% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 95.574% |
Almado, Inc. | 1.94 Billion JPY | 45.33% |
I-ne CO., LTD. | 8.57 Billion JPY | 87.595% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 78.195% |
Liberta Co.,Ltd. | 3.88 Billion JPY | 72.6% |
AXXZIA Inc. | 2 Billion JPY | 46.967% |
S.T. Corporation | 12.01 Billion JPY | 91.141% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 98.302% |
Earth Corporation | 60.4 Billion JPY | 98.238% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 86.355% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | 34.032% |
Ya-Man Ltd. | 3.97 Billion JPY | 73.24% |
MTG Co., Ltd. | 11.73 Billion JPY | 90.935% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | 74.495% |
SHOBIDO Corporation | 8.89 Billion JPY | 88.04% |
Artnature Inc. | 23.42 Billion JPY | 95.458% |
Pigeon Corporation | 19.34 Billion JPY | 94.501% |
Unicharm Corporation | 345.37 Billion JPY | 99.692% |
Paltac Corporation | 222.34 Billion JPY | 99.521% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 96.268% |